Skip to main content
Premium Trial:

Request an Annual Quote

Luminex, HTG Partner on Gene Expression Assay

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex and High Throughput Genomics have partnered to develop an integrated assay that Luminex will sell to the gene expression research market.

Luminex said today that the new qBead Gene Expression Assay puts HTG's qNPA chemistry technology on the Luminex xMAP multiplexing platform to create a high-throughput assay with a simplified workflow that requires no extractions, cDNA synthesis, or amplifications, Luminex said today.

The qBead assay is used to acquire gene expression data from degraded samples or difficult samples, such as formalin-fixed paraffin-embedded and other fixed tissues.

"The combination of xMAP Technology from Luminex and the qBead Assay represents an advance for many scientists, including cancer researchers who perform retrospective studies on large numbers of archived samples," Luminex CEO and President Patrick Balthrop said in a statement.

Balthrop also said that the partnership will use the two firms' technologies "to create high-throughput, custom assays that will advance the work of researchers in the critical, growing mid-plex custom gene expression research arena."

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.